Clinical Trial Update: Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an Inquiry Based Stress Reduction program for BRCA1/2 mutation carriers with hereditary breast and ovarian cancer syndrome has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Breast and Ovarian Cancer Syndrome

Snippet

Sponsor: Sheba Medical Center | Conditions: Hereditary Breast and Ovarian Cancer Syndrome | Phase 2 | Status: COMPLETED